Cargando…

Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study

OBJECTIVE: The purpose of this study was to compare duloxetine monotherapy to combination therapy with other antidepressants in patients with major depressive disorder in a clinical, real world setting. METHODS: An eight-week, retrospective, multi-center study of outpatients with major depressive di...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheon, Eun-Jin, Lee, Jun-Yeob, Choi, Joong-Hyeon, Lee, Young-Ji, Koo, Bon-Hoon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Neuropsychiatric Association 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965656/
https://www.ncbi.nlm.nih.gov/pubmed/27482247
http://dx.doi.org/10.4306/pi.2016.13.4.447
_version_ 1782445287887863808
author Cheon, Eun-Jin
Lee, Jun-Yeob
Choi, Joong-Hyeon
Lee, Young-Ji
Koo, Bon-Hoon
author_facet Cheon, Eun-Jin
Lee, Jun-Yeob
Choi, Joong-Hyeon
Lee, Young-Ji
Koo, Bon-Hoon
author_sort Cheon, Eun-Jin
collection PubMed
description OBJECTIVE: The purpose of this study was to compare duloxetine monotherapy to combination therapy with other antidepressants in patients with major depressive disorder in a clinical, real world setting. METHODS: An eight-week, retrospective, multi-center study of outpatients with major depressive disorder was undertaken. After screening 415 patients, enrolled in this study from July 2009 to June 2014 were 82 patients from among three centers who had been taking duloxetine with or without other antidepressant and not administered with atypical antipsychotics. We compared the mean changes of the Clinical Global Impression-Severity Scale (CGI-S) as a primary measure and the discontinuation rate as a secondary measure between the duloxetine monotherapy group (n=36, 43.9%) and the combination therapy with other antidepressants group (n=46, 56.1%) at baseline, one, two, four and eight weeks. RESULTS: There were no significant differences across the demographic characteristics between two groups. There was, however, a statistically greater improvement on the CGI-S at weeks 2, 4 and 8 in the combination group compared with the monotherapy group. There were no significant differences in discontinuation rate and adverse events between two groups. No serious adverse events were reported in both groups during the study period. CONCLUSION: This result suggests that the duloxetine combination therapy with other antidepressants could improve effectiveness and have comparable tolerability with the monotherapy in the treatment of outpatients with major depressive disorders in a naturalistic setting. Adequately powered, well-controlled clinical trials are strongly warranted to confirm our findings due to methodological shortcomings.
format Online
Article
Text
id pubmed-4965656
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Korean Neuropsychiatric Association
record_format MEDLINE/PubMed
spelling pubmed-49656562016-08-01 Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study Cheon, Eun-Jin Lee, Jun-Yeob Choi, Joong-Hyeon Lee, Young-Ji Koo, Bon-Hoon Psychiatry Investig Original Article OBJECTIVE: The purpose of this study was to compare duloxetine monotherapy to combination therapy with other antidepressants in patients with major depressive disorder in a clinical, real world setting. METHODS: An eight-week, retrospective, multi-center study of outpatients with major depressive disorder was undertaken. After screening 415 patients, enrolled in this study from July 2009 to June 2014 were 82 patients from among three centers who had been taking duloxetine with or without other antidepressant and not administered with atypical antipsychotics. We compared the mean changes of the Clinical Global Impression-Severity Scale (CGI-S) as a primary measure and the discontinuation rate as a secondary measure between the duloxetine monotherapy group (n=36, 43.9%) and the combination therapy with other antidepressants group (n=46, 56.1%) at baseline, one, two, four and eight weeks. RESULTS: There were no significant differences across the demographic characteristics between two groups. There was, however, a statistically greater improvement on the CGI-S at weeks 2, 4 and 8 in the combination group compared with the monotherapy group. There were no significant differences in discontinuation rate and adverse events between two groups. No serious adverse events were reported in both groups during the study period. CONCLUSION: This result suggests that the duloxetine combination therapy with other antidepressants could improve effectiveness and have comparable tolerability with the monotherapy in the treatment of outpatients with major depressive disorders in a naturalistic setting. Adequately powered, well-controlled clinical trials are strongly warranted to confirm our findings due to methodological shortcomings. Korean Neuropsychiatric Association 2016-07 2016-07-25 /pmc/articles/PMC4965656/ /pubmed/27482247 http://dx.doi.org/10.4306/pi.2016.13.4.447 Text en Copyright © 2016 Korean Neuropsychiatric Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Cheon, Eun-Jin
Lee, Jun-Yeob
Choi, Joong-Hyeon
Lee, Young-Ji
Koo, Bon-Hoon
Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title_full Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title_fullStr Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title_full_unstemmed Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title_short Effectiveness of Duloxetine Monotherapy Compared to Combination Therapy with Other Antidepressants in Patients with Major Depressive Disorder: A Short-Term, Retrospective Study
title_sort effectiveness of duloxetine monotherapy compared to combination therapy with other antidepressants in patients with major depressive disorder: a short-term, retrospective study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965656/
https://www.ncbi.nlm.nih.gov/pubmed/27482247
http://dx.doi.org/10.4306/pi.2016.13.4.447
work_keys_str_mv AT cheoneunjin effectivenessofduloxetinemonotherapycomparedtocombinationtherapywithotherantidepressantsinpatientswithmajordepressivedisorderashorttermretrospectivestudy
AT leejunyeob effectivenessofduloxetinemonotherapycomparedtocombinationtherapywithotherantidepressantsinpatientswithmajordepressivedisorderashorttermretrospectivestudy
AT choijoonghyeon effectivenessofduloxetinemonotherapycomparedtocombinationtherapywithotherantidepressantsinpatientswithmajordepressivedisorderashorttermretrospectivestudy
AT leeyoungji effectivenessofduloxetinemonotherapycomparedtocombinationtherapywithotherantidepressantsinpatientswithmajordepressivedisorderashorttermretrospectivestudy
AT koobonhoon effectivenessofduloxetinemonotherapycomparedtocombinationtherapywithotherantidepressantsinpatientswithmajordepressivedisorderashorttermretrospectivestudy